CoChat

Pharmacologic induction of fetal hemoglobin: raising the therapeutic bar in sickle cell disease

Atweh, George F., Schechter, Alan N. · 2001 · Current Opinion in Hematology

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Abstract

The favorable effects of high levels of fetal hemoglobin (Hb F) in sickle cell disease have been recognized for several decades. This has been an important incentive for the development of therapeutic agents that increase Hb F production. 5-Azacytidine, the first such agent in clinical use, was proposed based on a molecular understanding of the role of DNA methylation in globin gene regulation. Controversy over the mechanism of Hb F induction by 5-azacytidine led to the identification of hydroxyurea as another agent that can increase Hb F production. Although the clinical benefit of hydroxyurea has been demonstrated in a randomized clinical trial, greater increases in Hb F are clearly needed for optimal therapeutic effect. Butyrates also increase Hb F levels, and their use in combination with hydroxyurea appears to be synergistic. Now that multiple therapeutic agents are available for Hb F induction, the use of combination therapy to increase Hb F levels sufficiently to prevent all the complications of sickle cell disease has become a realistic goal.

Overview

Integrity signals

Registry

Crossref · 10.1097/00062752-200103000-00010

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 44 references

Research works printed but not linked: 7

  1. Steinberg, 2000, Blood, 96, 485a
  2. Sutton, 1999, Blood, 94, 416a
  3. Fruchtman, 1997, Semin Hematol, 34, 17
  4. Kinney, 1999, Blood, 94, 1550
  5. Atweh, 1999, Blood, 93, 1790
  6. Sutton, 1998, Blood, 92, 694a
  7. Steinberg, 1999, Blood, 94, 644a

Cited by

See all 66

Metadata

Authors
Atweh, G. F., & Schechter, A. N.
Affiliations
National Institutes of Health (US)
Corresponding author
Atweh, George F.
Venue
Current Opinion in Hematology
Published
2001-03
Volume
8
Issue
2
Pages
123-130
ISSN
1065-6251 (ISSN-L)
OpenAlex
W2108041597
Cited by
66
References
42
Citations by year
2025: 1 · 2024: 3 · 2021: 1 · 2019: 1 · 2018: 1 · 2017: 2 · 2016: 3 · 2015: 2 · 2013: 2 · 2012: 1
FWCI
1.53
Type
journal article
Language
en
Open access
closed
Locations
  • Current Opinion in Hematology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
  • Health Sciences › Medicine › Hematology › Blood groups and transfusion
Keywords
sickle cell disease, fetal hemoglobin induction, azacitidine, hydroxyurea, butyrate, DNA methylation, globin gene regulation, combination therapy, drug synergy
MeSH terms
Decitabine, Anemia, Sickle Cell, Azacitidine, Butyrates, Fetal Hemoglobin, Humans, Hydroxyurea

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacologic induction of fetal hemoglobin: raising the therapeutic bar in sickle cell disease. https://app.cochat.ai/papers/10.1097/00062752-200103000-00010
The paper
Atweh, G. F., & Schechter, A. N. (2001). Pharmacologic induction of fetal hemoglobin: raising the therapeutic bar in sickle cell disease. Current Opinion in Hematology. https://doi.org/10.1097/00062752-200103000-00010

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.